At a glance
- Originator Taisho Pharmaceutical
- Class Antipsychotics; Small molecules
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 05 Feb 1997 No-Development-Reported for Psychotic disorders in Japan (PO)
- 31 Oct 1994 Preclinical development for Psychotic disorders in Japan (PO)